← Back to Search

Behavioral Health Intervention for Developmental Disabilities (BEST Trial)

Q: Is this research endeavor actively seeking participants?

Data hosted on clinicaltrials.gov indicates that this trial is not presently recruiting patients, though it was originally posted in September of 2022 with a final update made in December of the same year. Fortunately, there are still 1382 other medical trials actively searching for volunteers at present.

Q: Is the age cutoff for enrollment in this trial above 20 years old?

This research is targeting adolescents aged 13-20 years of age.

Q: What criteria must a prospective patient fulfill to be accepted into this trial?

To participate in this study, candidates must be aged between 13 and 20 and demonstrate symptoms of <a href="https://www.withpower.com/clinical-trials/anxiety">anxiety</a>. 780 participants are needed for the trial to reach completion.

Q: What goals are the researchers attempting to achieve with this clinical trial?

The chief aim of this experiment, which spans a 24-month period from Baseline, is to gauge the effects of treatment on Depressive Symptomatology. Auxiliary parameters include Health Behaviors - Risk Behaviors that assess physical activity (score range 0 to 7 days/week), screen time (score range &#x3C;1hr to 5+ hours/day), and <a href="https://www.withpower.com/clinical-trials/sleep">sleep</a> (&#x3C;4hr to 10+ hr/day). Additionally, Self-Efficacy will be assessed with the Generalized Self-Efficacy Scale (GSE) containing ten items measuring one's capacity for coping with adversity through daily living activities;

N/A

Waitlist Available

Led By Kristin L Berg, PhD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline through 24 months

Awards & highlights

BEST Trial Summary

This trial is testing a combined mental health treatment and care coordination program for youth with disabilities to see if it helps them cope better with anxiety, depression, and manage their health better. 780 youth in Illinois will be randomly placed in either the combined program or care coordination alone.

Who is the study for?

This trial is for young people aged 13-20 with intellectual and/or developmental disabilities (IDD) who are enrolled in MCHB care in Illinois. They must be able to consent to the study and have at least a 4th-grade reading level. Those with severe intellectual disability (IQ <50) or very low comprehension skills are not eligible.Check my eligibility

What is being tested?

The BEST Study tests if adding mental health treatment to MCHB care coordination helps youth with IDD feel less anxious and depressed, healthier, function better, practice healthy habits, and manage their health more effectively compared to standard MCHB care coordination.See study design

What are the potential side effects?

Since this trial involves behavioral interventions like online programs and group meetings rather than medication, traditional side effects aren't expected. However, discussing sensitive topics could potentially cause temporary discomfort or emotional distress.

BEST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline through 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline through 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Anxiety Symptomatology

Anxiety Symptomatology of Caregiver

Depressive Symptomatology

+3 more

Secondary outcome measures

Adverse Childhood Experiences

Caregiver-Reported Adaptive Functioning

Cognitive Style

+17 more

Other outcome measures

Sociodemographic Information

BEST Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Illinois MCHB Care Coordination + CHECK tiered behavioral healthExperimental Treatment6 Interventions

MCHB Care Coordination plus CHECK: includes all elements of MCHB care coordination, described above, plus the CHECK program. The CHECK program consists of a trained, behavioral health care team; an evidence-based treatment algorithm to classify risk for depression and anxiety (minimal, subclinical and clinical symptomatology) and guide treatment advancement [Tier 1/selective: cognitive behavioral psycho-education; Tier 2/indicated: cognitive-behavioral prevention groups; Tier 3/treatment: individualized or group cognitive-behavioral treatment (CBT)]; as well as structures and processes to support communication, coordination and data sharing between MCHB care coordinators and CHECK staff.

Group II: Illinois MCHB Care CoordinationActive Control1 Intervention

MCHB Care Coordination is funded through the Social Security Act of 1935 Title V Maternal and Child Health Services Block Grant Program, this is the oldest and most universal care coordination model for children with I/DD. The University of Illinois Chicago Division of Specialized Care for Children (DSCC) is the Illinois (IL) state Title V MCHB care coordination agency and has annual contact with over 19,000 families and youth in IL. MCHB (known as DSCC) Care Coordination involves: comprehensive needs assessments, person-centered planning, and linkage to health care and social resources. MCHB care coordination has established efficacy, feasibility, and acceptability in improving child and family functioning, youth health, and health care access.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

608 Previous Clinical Trials

1,558,737 Total Patients Enrolled

26 Trials studying Depression

6,251 Patients Enrolled for Depression

Wellesley CollegeOTHER

4 Previous Clinical Trials

2,270 Total Patients Enrolled

4 Trials studying Depression

2,270 Patients Enrolled for Depression

The Arc of IllinoisUNKNOWN

Media Library

Adapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT) Clinical Trial Eligibility Overview. Trial Name: NCT05520983 — N/A

Depression Research Study Groups: Illinois MCHB Care Coordination + CHECK tiered behavioral health, Illinois MCHB Care Coordination

Depression Clinical Trial 2023: Adapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT) Highlights & Side Effects. Trial Name: NCT05520983 — N/A

Adapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05520983 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively seeking participants?

"Data hosted on clinicaltrials.gov indicates that this trial is not presently recruiting patients, though it was originally posted in September of 2022 with a final update made in December of the same year. Fortunately, there are still 1382 other medical trials actively searching for volunteers at present."

Answered by AI

Is the age cutoff for enrollment in this trial above 20 years old?

"This research is targeting adolescents aged 13-20 years of age."

Answered by AI

What criteria must a prospective patient fulfill to be accepted into this trial?

"To participate in this study, candidates must be aged between 13 and 20 and demonstrate symptoms of anxiety. 780 participants are needed for the trial to reach completion."

Answered by AI

What goals are the researchers attempting to achieve with this clinical trial?

"The chief aim of this experiment, which spans a 24-month period from Baseline, is to gauge the effects of treatment on Depressive Symptomatology. Auxiliary parameters include Health Behaviors - Risk Behaviors that assess physical activity (score range 0 to 7 days/week), screen time (score range <1hr to 5+ hours/day), and sleep (<4hr to 10+ hr/day). Additionally, Self-Efficacy will be assessed with the Generalized Self-Efficacy Scale (GSE) containing ten items measuring one's capacity for coping with adversity through daily living activities;"

Answered by AI

Recent research and studies

Journal of Affective DisordersJournal

The PHQ-8 as a Measure of Current Depression in the General Population

Kroenke, Kurt, Tara W. Strine, Robert L. Spitzer, Janet B.W. Williams, Joyce T. Berry, and Ali H. Mokdad. 2009. “The PHQ-8 as a Measure of Current Depression in the General Population”. Journal of Affective Disorders. Elsevier BV. doi:10.1016/j.jad.2008.06.026.

Archives of Internal MedicineJournal

A Brief Measure for Assessing Generalized Anxiety Disorder

Spitzer, Robert L., Kurt Kroenke, Janet B. W. Williams, and Bernd Löwe. 2006. “A Brief Measure for Assessing Generalized Anxiety Disorder”. Archives of Internal Medicine. American Medical Association (AMA). doi:10.1001/archinte.166.10.1092.

Journal of Behavior Therapy and Experimental PsychiatryJournal

Psychometric Properties of the Credibility/expectancy Questionnaire

Devilly, Grant J., and Thomas D. Borkovec. 2000. “Psychometric Properties of the Credibility/expectancy Questionnaire”. Journal of Behavior Therapy and Experimental Psychiatry. Elsevier BV. doi:10.1016/s0005-7916(00)00012-4.

American Journal of Preventive MedicineJournal